As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention.
Scientists in Germany have developed a new silicon-germanium chip that achieves the world’s highest combined sampling rate ...
Researchers used mass spectrometry to map the molecular composition of fetal bovine serum, identifying a core proteome ...
Researchers say the new chip achieves the highest combination of sampling rate and bandwidth ever demonstrated in a track-and ...
Glycotide Scam Searches, Complaints, and Side Effects Explained for Adults Comparing Metabolic Health Supplements in 2026 ...
Pharming Group (NASDAQ:PHAR) executives said first-quarter 2026 results reflected an expected decline in RUCONEST revenue tied largely to specialty pharmacy inventory movements and the company’s ...
MusicRadar on MSN
How Native Instruments’ Massive became the go-to bass synth for a generation of music-makers
This is the history of Native Instruments’ massively influential wavetable instrument, from development and release to its rebirth as Massive X Player ...
Early visual alpha oscillations correlate on a trial-by-trial basis with steady-state responses at later stages of the processing stream, implying a role in signal enhancement and interareal ...
The Brighterside of News on MSN
Study finds low-dose CAR T therapy can drive complete cancer remission
A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...
This blurring of traditional boundaries between nuclear medicine and radiation oncology creates both opportunities and ...
The biggest stories of the day delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results